These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 38744264

  • 1. M6A RNA Methylation-Mediated Dysregulation of AGAP2-AS1 Promotes Trastuzumab Resistance of Breast Cancer.
    Cai Y, Zheng H, Xu D, Xie J, Wang W, Liu Z, Zheng Z.
    Pharmacology; 2024; 109(5):282-292. PubMed ID: 38744264
    [Abstract] [Full Text] [Related]

  • 2. SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88.
    Dong H, Wang W, Mo S, Chen R, Zou K, Han J, Zhang F, Hu J.
    J Exp Clin Cancer Res; 2018 Aug 29; 37(1):202. PubMed ID: 30157918
    [Abstract] [Full Text] [Related]

  • 3. Increased Expression of Exosomal AGAP2-AS1 (AGAP2 Antisense RNA 1) In Breast Cancer Cells Inhibits Trastuzumab-Induced Cell Cytotoxicity.
    Zheng Z, Chen M, Xing P, Yan X, Xie B.
    Med Sci Monit; 2019 Mar 26; 25():2211-2220. PubMed ID: 30910994
    [Abstract] [Full Text] [Related]

  • 4. Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation.
    Han M, Gu Y, Lu P, Li J, Cao H, Li X, Qian X, Yu C, Yang Y, Yang X, Han N, Dou D, Hu J, Dong H.
    Mol Cancer; 2020 Feb 05; 19(1):26. PubMed ID: 32020881
    [Abstract] [Full Text] [Related]

  • 5. MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer.
    Han J, Qu H, Han M, Ding Y, Xie M, Hu J, Chen Y, Dong H.
    Oncogene; 2021 Jan 05; 40(4):833-847. PubMed ID: 33273726
    [Abstract] [Full Text] [Related]

  • 6. AGAP2-AS1 promotes the assembly of m6A methyltransferases and activation of the IL6/STAT3 pathway by binding with WTAP in the carcinogenesis of gastric cancer.
    Nie K, Zheng Z, Li J, Chang Y, Deng Z, Huang W, Li X.
    FASEB J; 2023 Dec 05; 37(12):e23302. PubMed ID: 37983949
    [Abstract] [Full Text] [Related]

  • 7. N6-methyladenosine-modified long non-coding RNA AGAP2-AS1 promotes psoriasis pathogenesis via miR-424-5p/AKT3 axis.
    Xian J, Shang M, Dai Y, Wang Q, Long X, Li J, Cai Y, Xia C, Peng X.
    J Dermatol Sci; 2022 Jan 05; 105(1):27-36. PubMed ID: 34930676
    [Abstract] [Full Text] [Related]

  • 8. lncRNA ZNF649-AS1 Induces Trastuzumab Resistance by Promoting ATG5 Expression and Autophagy.
    Han M, Qian X, Cao H, Wang F, Li X, Han N, Yang X, Yang Y, Dou D, Hu J, Wang W, Han J, Zhang F, Dong H.
    Mol Ther; 2020 Nov 04; 28(11):2488-2502. PubMed ID: 32735773
    [Abstract] [Full Text] [Related]

  • 9. Exosome-mediated transfer of lncRNA‑SNHG14 promotes trastuzumab chemoresistance in breast cancer.
    Dong H, Wang W, Chen R, Zhang Y, Zou K, Ye M, He X, Zhang F, Han J.
    Int J Oncol; 2018 Sep 04; 53(3):1013-1026. PubMed ID: 30015837
    [Abstract] [Full Text] [Related]

  • 10. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J, Xie H, Ying Y, Chen H, Yan H, He L, Xu M, Xu X, Liang Z, Liu B, Wang X, Zheng X, Xie L.
    Mol Cancer; 2020 Oct 29; 19(1):152. PubMed ID: 33121495
    [Abstract] [Full Text] [Related]

  • 11. XBP1s activates METTL3/METTL14 for ER-phagy and paclitaxel sensitivity regulation in breast cancer.
    Wang J, Fan P, Shen P, Fan C, Zhao P, Yao Shen, Dong K, Ling R, Chen S, Zhang J.
    Cancer Lett; 2024 Aug 01; 596():216846. PubMed ID: 38582397
    [Abstract] [Full Text] [Related]

  • 12. Effect of m6A methyltransferase METTL3 -mediated MALAT1/E2F1/AGR2 axis on adriamycin resistance in breast cancer.
    Li S, Jiang F, Chen F, Deng Y, Pan X.
    J Biochem Mol Toxicol; 2022 Jan 01; 36(1):e22922. PubMed ID: 34964205
    [Abstract] [Full Text] [Related]

  • 13. [Study on the Role and Mechanism of METTL3 Mediating the Up-regulation of 
m6A Modified Long Non-coding RNA THAP7-AS1 in Promoting the Occurrence of 
Lung Cancer].
    Zhang Y, Wang Y, Liu M.
    Zhongguo Fei Ai Za Zhi; 2024 Jan 02; 26(12):919-933. PubMed ID: 38163978
    [Abstract] [Full Text] [Related]

  • 14. Exosomal long noncoding RNA AGAP2-AS1 regulates trastuzumab resistance via inducing autophagy in breast cancer.
    Qian X, Qu H, Zhang F, Peng S, Dou D, Yang Y, Ding Y, Xie M, Dong H, Liao Y, Han M.
    Am J Cancer Res; 2021 Jan 02; 11(5):1962-1981. PubMed ID: 34094664
    [Abstract] [Full Text] [Related]

  • 15. Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer.
    Li W, Zhai L, Wang H, Liu C, Zhang J, Chen W, Wei Q.
    Oncotarget; 2016 May 10; 7(19):27778-86. PubMed ID: 27034004
    [Abstract] [Full Text] [Related]

  • 16. m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.
    Jin D, Guo J, Wu Y, Du J, Yang L, Wang X, Di W, Hu B, An J, Kong L, Pan L, Su G.
    J Hematol Oncol; 2019 Dec 09; 12(1):135. PubMed ID: 31818312
    [Abstract] [Full Text] [Related]

  • 17. Role of lncRNA AGAP2-AS1 in Breast Cancer Cell Resistance to Apoptosis by the Regulation of MTA1 Promoter Activity.
    Wu M, Wen L, Zhou Y, Wu W.
    Technol Cancer Res Treat; 2022 Dec 09; 21():15330338221085361. PubMed ID: 35369814
    [Abstract] [Full Text] [Related]

  • 18. TNFα-Induced Mucin 4 Expression Elicits Trastuzumab Resistance in HER2-Positive Breast Cancer.
    Mercogliano MF, De Martino M, Venturutti L, Rivas MA, Proietti CJ, Inurrigarro G, Frahm I, Allemand DH, Deza EG, Ares S, Gercovich FG, Guzmán P, Roa JC, Elizalde PV, Schillaci R.
    Clin Cancer Res; 2017 Feb 01; 23(3):636-648. PubMed ID: 27698002
    [Abstract] [Full Text] [Related]

  • 19. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z, Wang Y, Wang L, Yao B, Sun L, Liu R, Chen T, Niu Y, Tu K, Liu Q.
    J Exp Clin Cancer Res; 2019 May 14; 38(1):194. PubMed ID: 31088485
    [Abstract] [Full Text] [Related]

  • 20. Propofol attenuates prostate cancer progression by upregulating TRHDE-AS1 expression, and METTL14 could mediate its m6A modification.
    Chen Z, Li Q, Li Z, Hu G.
    Clin Exp Pharmacol Physiol; 2024 Nov 14; 51(11):e13924. PubMed ID: 39322401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.